These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 1553573

  • 61. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool.
    Carlesso N, Pregno P, Bresso P, Gallo E, Pileri A, Zsebo KM, Ferrero D.
    Leukemia; 1992 Jul; 6(7):642-8. PubMed ID: 1378162
    [Abstract] [Full Text] [Related]

  • 62. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
    Suzuki T, Bessho M, Hirashima K, Tohda S, Nagata K, Morio T, Imai Y, Nara N.
    J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
    [Abstract] [Full Text] [Related]

  • 63. CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders.
    Brach M, Stone R, Kufe D.
    Biotechnol Ther; 1991 Sep; 2(3-4):269-83. PubMed ID: 1845130
    [Abstract] [Full Text] [Related]

  • 64. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 65. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro.
    Katagiri T, Miyazawa K, Nishimaki J, Yaguchi M, Kawanishi Y, Ohyashiki K.
    Leuk Lymphoma; 2000 Sep; 39(1-2):173-84. PubMed ID: 10975397
    [Abstract] [Full Text] [Related]

  • 66. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of myeloid leukemia.
    Hoelzer D, Seipelt G.
    Curr Opin Hematol; 1995 May; 2(3):196-203. PubMed ID: 9371995
    [Abstract] [Full Text] [Related]

  • 67. Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: a flow cytometry study.
    Lacombe F, Puntous M, Dumain P, Cony-Makhoul P, Belloc F, Bernard P, Boisseau M, Reiffers J.
    Leuk Res; 1996 Jun; 20(6):481-9. PubMed ID: 8709620
    [Abstract] [Full Text] [Related]

  • 68. Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.
    Rossi HA, O'Donnell J, Sarcinelli F, Stewart FM, Quesenberry PJ, Becker PS.
    Leukemia; 2002 Mar; 16(3):310-5. PubMed ID: 11896533
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Effect of interleukin 3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts.
    Brach M, Klein H, Platzer E, Mertelsmann R, Herrmann F.
    Exp Hematol; 1990 Aug; 18(7):748-53. PubMed ID: 1696204
    [Abstract] [Full Text] [Related]

  • 71. Differential response to stem cell factor and Flt3 ligand by the FAB subtype in acute myeloid leukemia clonogenic cells.
    Murohashi I, Yoshida K, Kishimoto K, Takahashi T, Wakao D, Jinnai I, Yagasaki F, Kawai N, Suzuki T, Matsuda A, Hirashima K, Bessho M.
    J Interferon Cytokine Res; 2002 Mar; 22(3):335-41. PubMed ID: 12034041
    [Abstract] [Full Text] [Related]

  • 72. Different sensitivity of normal and leukaemic progenitor cells to Ara-C and IL-3 combined treatment.
    Lista P, Brizzi MF, Rossi M, Resegotti L, Clark SC, Pegoraro L.
    Br J Haematol; 1990 Sep; 76(1):21-6. PubMed ID: 2223644
    [Abstract] [Full Text] [Related]

  • 73. Intracellular pharmacodynamics of ara-C and flowcytometric analysis of cell cycle progression in leukemia chemotherapy.
    Nakamura T, Takauji R, Kamiya K, Kawai Y, Iwasaki H, Tohyama K, Yamauchi T, Ueda T.
    Leukemia; 1997 Apr; 11 Suppl 3():548-51. PubMed ID: 9209453
    [Abstract] [Full Text] [Related]

  • 74. Formation of cytosine arabinoside-5'-triphosphate in cultured human leukemic cell lines correlates with nucleoside transport capacity.
    Tanaka M, Yoshida S.
    Jpn J Cancer Res; 1987 Aug; 78(8):851-7. PubMed ID: 3115933
    [Abstract] [Full Text] [Related]

  • 75. A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia.
    Laver J, Shearer P, Krance R, Hurwitz CA, Srivastava DK, Weinstein HJ, Mirro J.
    Leuk Lymphoma; 1997 Aug; 26(5-6):589-93. PubMed ID: 9389365
    [Abstract] [Full Text] [Related]

  • 76. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K, Iki S, Endo M, Kitazume K, Ito K, Watanabe M, Urabe A.
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [Abstract] [Full Text] [Related]

  • 77. [Successful treatment of acute non-lymphoblastic leukemia from myelodysplastic syndrome by combination of human macrophage colony-stimulating factor (M-CSF) and low dose cytosine arabinoside: M-CSF-induced proliferation and tyrosine phosphorylation in leukemic blasts].
    Hagiwara S, Yuo A, Nagai M, Takezako N, Soda Y, Miwa A, Togawa A, Takaku F.
    Rinsho Ketsueki; 1996 Nov; 37(11):1259-64. PubMed ID: 8960658
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.